Sinofn Health
Sinofn Health
Melbourne, the capital of Victoria, Australia, is witnessing a significant transformation in its nutritional sector. As an SEO Growth Director, I observe that the "Silver Economy"—a result of an aging population—and the increasing prevalence of metabolic disorders are driving demand for FSMP (Foods for Special Medical Purposes). The regulatory environment in Australia, governed by FSANZ (Food Standards Australia New Zealand), is rigorous. Brands operating here require more than just a supplier; they need a strategic partner who understands clinical-grade documentation, stability testing, and regulatory compliance.
SINOFN bridges this gap. With our roots in the Chinese Academy of Sciences (CAS) and a robust commitment to clinical nutrition, we offer Australian brands a unique value proposition: the ability to scale specialized production without compromising on the strict quality mandates expected in the Melbourne market. Our factory serves as a hub for innovation, blending global health standards with cutting-edge nutraceutical delivery systems.
We provide stable, continuous supply chain solutions, mitigating the volatility often seen in global logistics for clinical nutrition products.
Leveraging CAS-backed research, we accelerate time-to-market for new formulations, from concept to commercialization.
By optimizing production processes, we ensure that premium-grade health products remain accessible, maintaining healthy margins for our Australian clients.
Founded by Mrs. GuoHong Liu, SINOFN was born out of a clinical mission to make specialized nutrition affordable. Our commitment to PKU foods and metabolic health isn't just business; it's a mission-driven approach that resonates with health professionals and institutions in Melbourne.
Led by Dr. Zhang Ying (CAS Postdoc) and Dr. Tan Shengjie (Peking University), our R&D team provides the technical authority required for complex medical formulations. Our partnership with Dutch senior scientists ensures our delivery technologies meet EU and international standards, perfectly suited for the high quality expectations of the Australian market.
Yes, we provide extensive documentation, including certificates of analysis (CoA), stability reports, and manufacturing specifications required for TGA and FSANZ compliance pathways.
Our facility is equipped with 10+ dedicated lines, capable of producing over 500 million units annually, with modular setup to allow for small-batch prototyping or large-scale production.
We implement a "Full-Plant Integration" model, using HPLC/GC-MS for contaminant screening, ensuring every batch meets international purity standards.
